Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)

BACKGROUND: A35 is a novel synthetic cyclizing-berberine recently patented as an antitumor compound. Based on its dual targeting topoisomerase (top) activity, A35 might overcome the resistance of single-target top inhibitors and has no cardiac toxicity for not targeting top2β. In this study we furth...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wuli, Liu, Hong, Wang, Junxia, Wang, Mengyan, Shao, Rongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935996/
https://www.ncbi.nlm.nih.gov/pubmed/29728107
http://dx.doi.org/10.1186/s13046-018-0759-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935996/
https://www.ncbi.nlm.nih.gov/pubmed/29728107
http://dx.doi.org/10.1186/s13046-018-0759-6

Ejemplares similares